Cargando…

Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors

The main protease of SARS‐CoV‐2 (M(pro)), the causative agent of COVID‐19, constitutes a significant drug target. A new fluorogenic substrate was kinetically compared to an internally quenched fluorescent peptide and shown to be ideally suitable for high throughput screening with recombinantly expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Breidenbach, Julian, Lemke, Carina, Pillaiyar, Thanigaimalai, Schäkel, Laura, Al Hamwi, Ghazl, Diett, Miriam, Gedschold, Robin, Geiger, Nina, Lopez, Vittoria, Mirza, Salahuddin, Namasivayam, Vigneshwaran, Schiedel, Anke C., Sylvester, Katharina, Thimm, Dominik, Vielmuth, Christin, Phuong Vu, Lan, Zyulina, Maria, Bodem, Jochen, Gütschow, Michael, Müller, Christa E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014119/ https://www.ncbi.nlm.nih.gov/pubmed/33655614 http://dx.doi.org/10.1002/anie.202016961

Ejemplares similares

6-(Ar)Alkylamino-Substituted Uracil Derivatives: Lipid Mimetics with Potent Activity at the Orphan G Protein-Coupled Receptor 84 (GPR84)
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2018)

Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2017)

Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors
por: Geiger, Nina, et al.
Publicado: (2023)

An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2016)

A Cellular Assay for the Identification and Characterization of Connexin Gap Junction Modulators
por: Danish, Azeem, et al.
Publicado: (2021)

Nucleotide Analog ARL67156 as a Lead Structure for the Development of CD39 and Dual CD39/CD73 Ectonucleotidase Inhibitors
por: Schäkel, Laura, et al.
Publicado: (2020)

Design, Synthesis and Biological Evaluation of Highly Potent Simplified Archazolids
por: Rivière, Solenne, et al.
Publicado: (2020)

Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice
por: Hess, Cornelius, et al.
Publicado: (2016)

Recent discovery and development of inhibitors targeting coronaviruses
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

Reaction of indoles with aromatic fluoromethyl ketones: an efficient synthesis of trifluoromethyl(indolyl)phenylmethanols using K(2)CO(3)/n-Bu(4)PBr in water
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

Activating endogenous resolution pathways by soluble epoxide hydrolase inhibitors for the management of COVID‐19
por: Manickam, Manoj, et al.
Publicado: (2021)

Iodine-catalyzed electrophilic substitution of indoles: Synthesis of (un)symmetrical diindolylmethanes with a quaternary carbon center
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2021)

COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease
por: Kronenberger, Thales, et al.
Publicado: (2023)

A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

The recent outbreaks of human coronaviruses: A medicinal chemistry perspective
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)

Recommended tool compounds and drugs for blocking P2X and P2Y receptors
por: Müller, Christa E., et al.
Publicado: (2021)

Protein kinase inhibitor ceritinib blocks ectonucleotidase CD39 – a promising target for cancer immunotherapy
por: Schäkel, Laura, et al.
Publicado: (2022)

Inhibitor induced conformational changes in SARS-COV-2 papain-like protease
por: Ferreira, Glaucio Monteiro, et al.
Publicado: (2022)

Involvement of GPR17 in Neuronal Fibre Outgrowth
por: Braune, Max, et al.
Publicado: (2021)

Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1) – a promising target for the immunotherapy of cancer
por: Lopez, Vittoria, et al.
Publicado: (2023)

Sulfated Polysaccharides from Macroalgae Are Potent Dual Inhibitors of Human ATP-Hydrolyzing Ectonucleotidases NPP1 and CD39
por: Lopez, Vittoria, et al.
Publicado: (2021)

Chemistry and Analysis of Organic Compounds in Dinosaurs
por: Tahoun, Mariam, et al.
Publicado: (2022)

Discovery of Polyphenolic Natural Products as SARS-CoV-2 M(pro) Inhibitors for COVID-19
por: Krüger, Nadine, et al.
Publicado: (2023)

Irreversible Antagonists for the Adenosine A(2B) Receptor †
por: Temirak, Ahmed, et al.
Publicado: (2022)

HD_BPMDS: a curated binary pattern multitarget dataset of Huntington’s disease–targeting agents
por: Stefan, Sven Marcel, et al.
Publicado: (2023)

Computational Investigations on the Binding Mode of Ligands for the Cannabinoid-Activated G Protein-Coupled Receptor GPR18
por: Neumann, Alexander, et al.
Publicado: (2020)

The Activation of GPR27 Increases Cytosolic L-Lactate in 3T3 Embryonic Cells and Astrocytes
por: Dolanc, Dorian, et al.
Publicado: (2022)

Cell‐permeable high‐affinity tracers for G(q) proteins provide structural insights, reveal distinct binding kinetics and identify small molecule inhibitors
por: Kuschak, Markus, et al.
Publicado: (2020)

An Overview of Spike Surface Glycoprotein in Severe Acute Respiratory Syndrome–Coronavirus
por: Kathiravan, Muthu Kumaradoss, et al.
Publicado: (2021)

Binding mode analysis of ABCA7 for the prediction of novel Alzheimer's disease therapeutics
por: Namasivayam, Vigneshwaran, et al.
Publicado: (2021)

Strategies in the Design and Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
por: Vanangamudi, Murugesan, et al.
Publicado: (2023)

Coumarin as a structural component of substrates and probes for serine and cysteine proteases
por: Breidenbach, Julian, et al.
Publicado: (2020)

A curated binary pattern multitarget dataset of focused ATP-binding cassette transporter inhibitors
por: Stefan, Sven Marcel, et al.
Publicado: (2022)

Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies
por: Thanigaimalai, Pillaiyar, et al.
Publicado: (2013)

Substrate-Dependence of Competitive Nucleotide Pyrophosphatase/Phosphodiesterase1 (NPP1) Inhibitors
por: Lee, Sang-Yong, et al.
Publicado: (2017)

C@PA: Computer-Aided Pattern Analysis to Predict Multitarget ABC Transporter Inhibitors
por: Namasivayam, Vigneshwaran, et al.
Publicado: (2021)

Scaffold fragmentation and substructure hopping reveal potential, robustness, and limits of computer-aided pattern analysis (C@PA)
por: Namasivayam, Vigneshwaran, et al.
Publicado: (2021)

Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety
por: Konno, Sho, et al.
Publicado: (2013)

Multi-omics for COVID-19: driving development of therapeutics and vaccines
por: Guo, Mengyu, et al.
Publicado: (2023)

Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific
por: Diesendorf, Viktoria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t806bmpq0eilvepp9fqm3icg3i